Avid Bioservices Operating Income

Avid Bioservices (CDMO) currently reports a operating income of $-20M as of October 2024. That compares with $-11M in the prior-year period — down 79.7% year over year. Use the charts on this page to explore Avid Bioservices's operating income history and peer comparisons.

Avid Bioservices's operating income decreased from $-11M to $-20M — a 79.7% year-over-year decrease (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices reported $-20M in operating income as of October 2024. That compares with $-11M in the prior-year period — down 79.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.

Avid Bioservices is classified in the Healthcare sector. On operating income, it currently shows $-20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDMO with unrelated industries.